Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Revenue: €15.2B (+15% constant rates, +13% reported) | Recurring Operating Income: €6.2B (40.5% margin) | Net Profit: €4.6B (30.3% margin) | Q4: +18% growth | Leather goods +16.4%, Ready-to-wear +13.6%
Hermès is a French luxury goods manufacturer renowned for its high-end leather goods, fashion accessories, perfumes, and ready-to-wear collections that represent the pinnacle of craftsmanship and exclusivity. The company serves ultra-high-net-worth individuals and affluent consumers worldwide who seek handcrafted, timeless luxury products that represent status, heritage, and exceptional quality. Hermès has built its prestige through artisanal production methods, iconic products like the Birkin and Kelly bags, and a commitment to traditional craftsmanship that ensures each item is a unique work of art commanding premium prices.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.